Leukemia

Last updated: 01 November 2019

You can legally access new medicines, even if they are not approved in your country.

Learn more »

In a recent trial, 80% of patients with (MRD)-positive acute lymphoblastic leukemia (ALL) who were treated with a drug called Blincyto (blinatumomab) achieved a complete response.

Read more